NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
Publication
, Journal Article
Gradishar, WJ; Anderson, BO; Balassanian, R; Blair, SL; Burstein, HJ; Cyr, A; Elias, AD; Farrar, WB; Forero, A; Giordano, SH; Goetz, MP ...
Published in: J Natl Compr Canc Netw
April 2017
These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2017
Volume
15
Issue
4
Start / End Page
433 / 451
Location
United States
Related Subject Headings
- Sentinel Lymph Node Biopsy
- Oncology & Carcinogenesis
- Neoplasm Staging
- Humans
- Female
- Disease Management
- Combined Modality Therapy
- Breast Neoplasms
- Axilla
- 4203 Health services and systems
Citation
APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., … Kumar, R. (2017). NCCN Guidelines Insights: Breast Cancer, Version 1.2017. J Natl Compr Canc Netw, 15(4), 433–451. https://doi.org/10.6004/jnccn.2017.0044
Gradishar, William J., Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, et al. “NCCN Guidelines Insights: Breast Cancer, Version 1.2017.” J Natl Compr Canc Netw 15, no. 4 (April 2017): 433–51. https://doi.org/10.6004/jnccn.2017.0044.
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. NCCN Guidelines Insights: Breast Cancer, Version 1.2017. J Natl Compr Canc Netw. 2017 Apr;15(4):433–51.
Gradishar, William J., et al. “NCCN Guidelines Insights: Breast Cancer, Version 1.2017.” J Natl Compr Canc Netw, vol. 15, no. 4, Apr. 2017, pp. 433–51. Pubmed, doi:10.6004/jnccn.2017.0044.
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, McCormick B, Moran MS, O’Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. NCCN Guidelines Insights: Breast Cancer, Version 1.2017. J Natl Compr Canc Netw. 2017 Apr;15(4):433–451.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2017
Volume
15
Issue
4
Start / End Page
433 / 451
Location
United States
Related Subject Headings
- Sentinel Lymph Node Biopsy
- Oncology & Carcinogenesis
- Neoplasm Staging
- Humans
- Female
- Disease Management
- Combined Modality Therapy
- Breast Neoplasms
- Axilla
- 4203 Health services and systems